Cure Alzheimer's Fund Cure Alzheimer's Fund

Since our inception in 2004, our steadfast focus has been providing research grants to the worlds’ leading scientists researching Alzheimer’s disease. We are honored to work with scientists who are passionate in their pursuit to rid our world of this debilitating disease.

Many of the funded projects have resulted in significant breakthroughs in developing a better understanding of Alzheimer’s disease and getting closer to a cure.


Search

Title Researchers Date
Neuroimmune Consortium: Neuroimmune Mechanisms Linking Peripheral Infection-Induced Dysregulation of Perivascular Amyloid Beta Clearance and Amyloid Pathology Beth Stevens 2026-06-03
Neuroimmune Consortium: Astrocyte Inflammatory Contributions to Alzheimer’s Disease Shane Liddelow 2026-06-03
Neuroimmune Consortium: Understanding Responses of the Brain to Peripheral Sources of Inflammation Christopher K. Glass 2026-06-03
Neuroimmune Consortium: APOE-Dependent Microglial Antigen Presentation Links Peripheral Inflammation to Neuroimmune Dysfunction Martine Therrien 2026-06-02
Brain Entry and Exit Consortium: Integrative Modeling and Experimental Characterization of Glymphatic–Lymphatic Transport for Enhanced Brain Waste Clearance Roger D. Kamm Ming Guo Se Hoon Choi 2026-06-02
Brain Entry and Exit Consortium: Failure of Polarized Brain Waste Clearance as an Early Driver of Alzheimer’s Disease Maiken Nedergaard 2026-06-02
Brain Entry and Exit Consortium: How Does Vascular Fatty Acid Metabolism Regulate the Pathophysiology of Alzheimer’s Disease? Richard Daneman 2026-06-02
Brain Entry and Exit Consortium: High-Resolution MRI and Molecular Pathology of the Primate Brain Borders Daniel S. Reich 2026-06-02
Brain Entry and Exit Consortium: Meningeal Lymphatic-CSF Axis and Its Dysfunction in Aging and Alzheimer’s Disease Jonathan Kipnis 2026-06-02
Neuroimmune Consortium: Examining the Mechanisms That Underlie Human Monocyte-Induced Neurodegeneration Mathew Blurton-Jones 2026-06-02
Linking Tau Pathology to Inflammatory Cell Death in Alzheimer’s Disease Nikolaos Louros 2026-05-30
Sleep and Circadian Rhythms Consortium: Targeting Sleep-Immuno-Metabolic Pathways in Preclinical Alzheimer’s Disease Yo-El Ju 2026-05-14
Sleep and Circadian Rhythms Consortium: Microglial Immunometabolism as a Mechanism for Sleep Loss in Alzheimer’s Disease Shannon Macauley 2026-05-14
Sleep and Circadian Rhythms Consortium: Renormalizing the Vascular Clock in Alzheimer’s Disease Eng H. Lo Mary Harrington 2026-05-14
Sleep and Circadian Rhythms Consortium: Immune Regulation of Sleep in Tauopathy Cameron McAlpine 2026-05-14
Sleep and Circadian Rhythms Consortium: The Role of Oligodendroglia in Alzheimer’s Disease-Associated Sleep Dysregulation Erin M. Gibson 2026-05-14
Sleep and Circadian Rhythms Consortium: Augmenting Circadian Rhythms to Mitigate Alzheimer’s Disease Pathogenesis Erik S. Musiek 2026-05-13
Targeting Exercise Mediators to Replicate Exercise Benefits in Neurodegeneration Se Hoon Choi Christiane Wrann 2026-04-24
Platelet Delivered 3D6 (anti-amyloid beta) with Marimastat to Stabilize Cerebrovascular Integrity and Reduce CAA Burden Erica Weekman Maegan Capitano 2026-04-10
Interrogating Roles of Brain Extracellular Matrix Proteins in Alzheimer’s Pathology Joseph Castellano 2026-04-06